Prenatal opioid exposure is a major health concern in the United States, with the incidence
of neonatal opioid withdrawal syndrome (NOWS) escalating in recent years. NOWS occurs …

The opioid epidemic led to an increase in the number of neonatal opioid withdrawal
syndrome (NOWS) cases in infants born to opioid-dependent mothers. Hallmark features of …

Introduction Infants exposed to opioids in utero are at high risk of exhibiting Neonatal Opioid
Withdrawal Syndrome (NOWS), a combination of somatic withdrawal symptoms including …

Populations affected by the ongoing opioid epidemic include pregnant women and their
offspring. Infants exposed to opioids in utero are at risk of developing Neonatal Opioid …

Introduction Opioid use during pregnancy and subsequent neonatal opioid withdrawal
syndrome (NOWS) have been associated with poor developmental outcomes including …

As the opioid epidemic continues to grow, opioid use among pregnant women is increasing
significantly. This has led to a steady rise in the number of infants born with neonatal opioid …

Rationale In utero opioid exposure is associated with lower weight and a neonatal opioid
withdrawal syndrome (NOWS) at birth, along with longer-term adverse neurodevelopmental …

Every fifteen minutes, a baby is born in the US experiencing neonatal opioid withdrawal
syndrome (NOWS). Since 2004, the rate of NOWS has increased 7-fold. Clinical studies …

The devastating impact of opioid abuse and dependence on the individual, family, and
society are well known but extremely difficult to combat. During pregnancy, opioid drugs and …

Neonatal opioid withdrawal syndrome (NOWS) is a growing public health concern. The
complexity of in utero opioid exposure in clinical studies makes it difficult to investigate …